• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度脂蛋白调节与心脏代谢和炎症相关疾病的风险:关注胆固醇外排能力。

HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity.

机构信息

Department of Cardiology, the Xiamen Cardiovascular Hospital of Xiamen University, Xiamen, Fujian, China.

Department of Cardiology, the Xiamen Cardiovascular Hospital of Xiamen University, Xiamen, Fujian, China.

出版信息

Int Immunopharmacol. 2024 Sep 10;138:112622. doi: 10.1016/j.intimp.2024.112622. Epub 2024 Jul 6.

DOI:10.1016/j.intimp.2024.112622
PMID:38971111
Abstract

Dyslipidemia, characterized by higher serum concentrations of low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), triglyceride (TG), and lower serum concentrations of high-density lipoprotein cholesterol (HDL-C), is confirmed as a hallmark of cardiovascular diseases (CVD), posing serious risks to the future health of humans. Aside from the role of HDL-C concentrations, the capacity of cholesterol efflux to HDL is being identified as an enssential messurement for the dyslipidemic morbidity. Through inducing the progression of reverse cholesterol transport (RCT), the HDL-related cholesterol efflux plays a vital role in atherosclerotic plaque formation. In addition, increasing results demonstrated that the relationships between cholesterol efflux and cardiovascular events might be influenced by multiple factors, such as atherosclerosis, diabetes, and, inflammatory diseases. These risk factors could affect the intracellular composition of HDL, which might subsqently influence the cholesterol efflux process induced by HDL particle. In the present comprehensive article, we summarize the latest findings which described the modulatory roles of HDL in cardiometabolic disorders and inflammatory related diseases, focusing on its capacity in mediating cholesterol efflux. Moreover, the potential mechanisms whereby HDL regulate the risk of cardiometabolic disorders or inflammatory related diseases, at least partly, via cholesterol efflux pathway, are also well-listed.

摘要

血脂异常表现为血清低密度脂蛋白胆固醇(LDL-C)、极低密度脂蛋白胆固醇(VLDL-C)、甘油三酯(TG)浓度升高,高密度脂蛋白胆固醇(HDL-C)浓度降低,这已被确认为心血管疾病(CVD)的标志,对人类未来的健康构成严重威胁。除了 HDL-C 浓度的作用外,胆固醇流出到 HDL 的能力也被认为是血脂异常发病的重要衡量标准。通过诱导胆固醇逆向转运(RCT)的进展,HDL 相关的胆固醇外排在动脉粥样硬化斑块形成中起着至关重要的作用。此外,越来越多的结果表明,胆固醇外排与心血管事件之间的关系可能受到多种因素的影响,如动脉粥样硬化、糖尿病和炎症性疾病。这些危险因素可能会影响 HDL 的细胞内组成,从而影响由 HDL 颗粒诱导的胆固醇外排过程。在本综述文章中,我们总结了最新的发现,描述了 HDL 在代谢性心血管疾病和炎症相关疾病中的调节作用,重点介绍了其介导胆固醇外排的能力。此外,还详细列出了 HDL 通过胆固醇外排途径调节代谢性心血管疾病或炎症相关疾病风险的潜在机制。

相似文献

1
HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity.高密度脂蛋白调节与心脏代谢和炎症相关疾病的风险:关注胆固醇外排能力。
Int Immunopharmacol. 2024 Sep 10;138:112622. doi: 10.1016/j.intimp.2024.112622. Epub 2024 Jul 6.
2
High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.高密度脂蛋白胆固醇流出能力与自身免疫性和非自身免疫性疾病的心血管风险。
Metabolism. 2020 Mar;104:154141. doi: 10.1016/j.metabol.2020.154141. Epub 2020 Jan 8.
3
HDL cholesterol efflux capacity and incident cardiovascular events.高密度脂蛋白胆固醇流出能力与心血管事件的发生
N Engl J Med. 2014 Dec 18;371(25):2383-93. doi: 10.1056/NEJMoa1409065. Epub 2014 Nov 18.
4
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.贝特类药物和烟酸缓释剂对血脂异常患者高密度脂蛋白颗粒大小分布和胆固醇流出能力的影响差异。
J Clin Lipidol. 2013 Sep-Oct;7(5):414-22. doi: 10.1016/j.jacl.2013.06.007. Epub 2013 Jun 27.
5
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).胆固醇流出能力、高密度脂蛋白颗粒数量与心血管事件发生率:来自JUPITER试验(他汀类药物在预防中的应用依据:一项评估瑞舒伐他汀的干预试验)的分析
Circulation. 2017 Jun 20;135(25):2494-2504. doi: 10.1161/CIRCULATIONAHA.116.025678. Epub 2017 Apr 27.
6
High-density lipoprotein functionality in cholesterol efflux in early childhood is related to the content ratio of triglyceride to cholesterol.高密度脂蛋白在儿童早期胆固醇外排中的功能与甘油三酯与胆固醇的含量比值有关。
Sci Rep. 2024 Oct 7;14(1):23323. doi: 10.1038/s41598-024-74699-5.
7
Cholesterol efflux and reverse cholesterol transport.胆固醇流出与胆固醇逆向转运。
Handb Exp Pharmacol. 2015;224:181-206. doi: 10.1007/978-3-319-09665-0_4.
8
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.新型选择性过氧化物酶体增殖物激活受体α调节剂(SPPARMα)匹伐他汀可改善血脂异常,增强胆固醇逆向转运,并减轻炎症和动脉粥样硬化。
Atherosclerosis. 2016 Jun;249:200-8. doi: 10.1016/j.atherosclerosis.2016.03.003. Epub 2016 Mar 4.
9
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.载脂蛋白-1 酶活性的降低可能导致 2 型糖尿病患者 HDL 颗粒的定性损伤。
Diabetes Res Clin Pract. 2013 Jan;99(1):30-8. doi: 10.1016/j.diabres.2012.10.022. Epub 2012 Nov 5.
10
Cardiovascular disease and dyslipidemia: beyond LDL.心血管疾病与血脂异常:不止于 LDL。
Curr Pharm Des. 2011;17(9):861-70. doi: 10.2174/138161211795428858.

引用本文的文献

1
Unraveling the Causal Links Between Immune Cells, Lipids, and Cardiovascular Diseases: Insights from Mendelian Randomization.解析免疫细胞、脂质与心血管疾病之间的因果联系:孟德尔随机化研究的见解
Glob Heart. 2025 Jul 3;20(1):57. doi: 10.5334/gh.1444. eCollection 2025.
2
Associations between retinal thickness and background factors in eyes without retinal diseases.无视网膜疾病眼中视网膜厚度与背景因素之间的关联。
Sci Rep. 2025 Jul 1;15(1):21796. doi: 10.1038/s41598-025-06863-4.
3
Evaluation and comparison of inflammatory and insulin resistance indicators on recurrent cardiovascular events in patients undergoing percutaneous coronary intervention: a single center retrospective observational study.
经皮冠状动脉介入治疗患者复发性心血管事件中炎症和胰岛素抵抗指标的评估与比较:一项单中心回顾性观察研究
Diabetol Metab Syndr. 2025 May 16;17(1):157. doi: 10.1186/s13098-025-01687-8.
4
Association between air pollution and cardiovascular disease risk in middle-aged and elderly individuals with diabetes: inflammatory lipid ratio accelerate this progression.空气污染与中老年糖尿病患者心血管疾病风险之间的关联:炎症性脂质比率加速了这一进程。
Diabetol Metab Syndr. 2025 Feb 21;17(1):65. doi: 10.1186/s13098-025-01638-3.